References
- Doege KW. FIBRO-SARCOMA OF THE
MEDIASTINUM. Ann Surg. Nov 1930;92(5):955-60.
- Potter, R.P. Intrathoracic
Tumors. Radiology. Jan 1930;14(1):60–1.
- Han G, Zhang Z, Shen X, Wang K,
Zhao Y, He J. Doege-Potter syndrome: A review of the literature
including a new case report. Medicine (Baltimore). July
2017;96(27):e7417-7417.
- Chamberlain MH, Taggart DP.
Solitary fibrous tumor associated with hypoglycemia: an example of the
Doege-Potter syndrome. The Journal of Thorac Cardiovascular Surgery,
Jan 2000; 119(1), 185–7.
- Lopez‐Hinostroza M, Salazar JM,
Dávila J, Absencio AY, Contreras‐Pulache H. Doege–Potter syndrome due
to endothoracic solitary hypoglycemic fibrous tumor. Sept 2021.http://dx.doi.org/10.22541/au.163257050.05408155/v1
- Fukuda I, Hizuka N, Ishikawa Y,
Yasumoto K, Murakami Y, Sata A, Morita J, Kurimoto M, Okubo Y, Takano
K. Clinical features of insulin-like growth factor-II producing
non-islet-cell tumor hypoglycemia. Growth Hormone and IGF Research.
Aug 2016;16(14):211-6.
- Mohammed T, Ozcan G, Siddique
AS, Araneta Iii RN, Slater DE, Khan A. Doege-Potter Syndrome with a
Benign Solitary Fibrous Tumor: A Case Report and Literature Review.
Case Rep Oncol. Mar 2021;14(1):470–6.
- Meng W, Zhu HH, Li H, Wang G,
Wei D, Feng X. Solitary fibrous tumors of the pleura with Doege-Potter
syndrome: a case report and three-decade review of the literature. BMC
Res Notes. Aug 2014;7:515-515.
- Denley A, Wallace JC, Cosgrove
LJ, Forbes BE. The insulin receptor isoform exon 11- (IR-A) in cancer
and other diseases: a review. Horm Metab Res 2003;35(11-12):778–85.
- de Groot JWB, Rikhof B, van
Doorn J, Bilo HJG, Alleman MA, Honkoop AH. Non-islet cell
tumour-induced hypoglycaemia: a review of the literature including two
new cases. Endocrine Related Cancer. Dec 2007;14(4):979-93.
- LeRoith D, Roberts CT. The
insulin-like growth factor system and cancer. Cancer Letters June
2003;195(2):127–37.
- Daughaday WH, Kapadia M.
Significance of abnormal serum binding of insulin-like growth factor
II in the development of hypoglycemia in patients with non-islet-cell
tumors. Proceedings of the National Academy of Sciences. Sept
1989;86(17):6778–82.
- Frystyk J, Skjærbæk C, Zapf J,
Ørskov H. Increased levels of circulating free insulin-like growth
factors in patients with non-islet cell tumour hypoglycaemia.
Diabetologia. Apr 1998;41(5):589–94.
- Bensinger SJ, Christofk HR. New
aspects of the Warburg effect in cancer cell biology. Seminars in Cell
& Developmental Biology, Cancer Cell Metabolism & Notch Signaling.
June 2012;23(4):352–61.
- Wignall OJ, Moskovic EC, Thway
K, Thomas JM. Solitary Fibrous Tumors of the Soft Tissues: Review of
the Imaging and Clinical Features With Histopathologic Correlation.
American Journal of Roentgenology. July 2010;195(1):W55–W62.
- Miraki-Moud F, Grossman AB,
Besser M, Monson JP, Camacho-Hübner C. A Rapid Method for Analyzing
Serum Pro-Insulin-Like Growth Factor-II in Patients with Non-Islet
Cell Tumor Hypoglycemia. The Journal of Clinical Endocrinology &
Metabolism, July 2005;90(7):3819–23.
- Zapf J, Schmid C, Guler HP,
Waldvogel M, Hauri C, Futo E, Hossenlopp P, Binoux M, Froesch ER.
Regulation of binding proteins for insulin-like growth factors (IGF)
in humans. Increased expression of IGF binding protein 2 during IGF I
treatment of healthy adults and in patients with extrapancreatic tumor
hypoglycemia. J Clin Invest. Sept 1990;86(3), 952–61.
- Jin K, Zhong S, Lin L, Wu J,
Wang Y, Cui W. Targeting-intratumoral-lactic-acidosis
transcatheter-arterial-chemoembolization for non-islet cell tumor
hypoglycemia secondary to a liver metastatic solitary fibrous tumor: A
case report and literature review. Front Endocrinol (Lausanne). Aug
2022;13:955687-955687.
- Haas RL, Walraven I,
Lecointe-Artzner E, Scholten AN, van Houdt WJ, Griffin AM. Radiation
Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A
Retrospective Study From the Global SFT Initiative in Collaboration
With the Sarcoma Patients EuroNet. International Journal of Radiation
Oncology Biology Physics. Aug 2018;101(5):1226-33.
- Bodnar TW, Acevedo MJ,
Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a
clinical review. J Clin Endocrinol Metab. Mar 2014;99(3):713-22.
- Ma RCW, Tong PCY, Chan JCN,
Cockram CS, Chan MHM. A 67-year-old woman with recurrent hypoglycemia:
non-islet cell tumour hypoglycemia. CMAJ. Aug 2005;173(4):359-61.
- Demicco EG, Wagner MJ, Maki RG,
Gupta V, Iofin I, Lazar AJ. Risk assessment in solitary fibrous
tumors: validation and refinement of a risk stratification model. Mod
Pathology. Oct 2017;30(10):1433-42.
- Herold G. Innere Medizin 2020
(internet). De Gruyter; 2020.
https://books.google.de/books?id=pL3tDwAAQBAJ
- Rinke A, Müller HH,
Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati
B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R, PROMID
Study Group. Placebo-controlled, double-blind, prospective, randomized
study on the effect of Octreotide LAR in the control of tumor growth
in patients with metastatic neuroendocrine midgut tumors: a report
from the PROMID Study Group. Journal of Clinical Oncology Oct
2009;27(28):4656-63.
- Stueven AK, Kayser A, Wetz C,
Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H.
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors:
Past, Present and Future. Int J Mol Sci. June 2019;20(12):3049.
- Reubi JC, Schär JC, Waser B,
Wenger S, Heppeler A, Schmitt JS, u. a. Affinity profiles for human
somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers
selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med.
März 2000;27(3):273–82.
- Lococo F, Rufini V, Filice A,
Paci M, Rindi G. 68Ga-DOTATOC PET/CT in Pleural Solitary Fibrous
Tumors. Clinical Nuclear Medicine. Juni 2021;46(6):e336.